Word Learning From Parentese in Autistic Children
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-59
SponsorThe University of Texas at Dallas
About this trial
The overall objective of this research is to determine whether parentese delivered in the video format (Aim 1) and in live interaction (Aim 2) facilitates novel word learning in autistic children and to investigate if there are factors that influence the effect of parentese on word learning (Aim 3).
Eligibility criteria
This trial accepts healthy volunteersQualifiers
children with or without a diagnosis of ASD between 18 and 59 months
Disqualifiers
hears another language more than 10% of time based on parent report
has uncorrected visual impairment or hearing impairment
has developmental disorders or medical conditions other than ASD that affect language or cognition (excepting psychiatric conditions often comorbid with ASD such as ADHD)
Trial design
Design model
Parallel
Treatments tested in this trial
Parentese Speech
BehavioralNovel words are introduced in parentese, a type of speech that is typically characterized by greater pitch variation, longer duration, and louder volume
Adult Registered Speech
BehavioralNovel words are introduced in standard adult register.
Treatment groups
100 Participants
are divided into 2 treatment groupsGroup A: ParenteseExperimental treatment 1 intervention
Group B: Adult RegisterActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
Proportion of time during which children's eye gaze is directed toward the target object
Children's eye gaze is recorded as they look at images. The proportion of time during which gaze is directed to an image of the targeted word is the dependent measure.
Time frame
300 ms after the target words are introducedSponsors and contacts
Click on the lead sponsor to view all of their trials.
The University of Texas at Dallas
Lead sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator
Source ClinicalTrials.gov